Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Active tea catechin eases radiation burns

20 Jun 2022

Epigallocatechin-3-gallate, a catechin that is most potent and abundant in tea, is a potential skin care solution in patients receiving radiotherapy, with a phase II study showing that it helps reduce the incidence and severity of radiation-induced dermatitis.

Active tea catechin eases radiation burns

20 Jun 2022

Adjuvant radiation halves recurrence risk in cutaneous squamous cell carcinoma

19 Jun 2022

Adjuvant radiation (ART) after a clear margin surgery reduces the risk of local recurrence and locoregional recurrence in patients with high T-stage cutaneous squamous cell carcinomas, reports a recent study.

Adjuvant radiation halves recurrence risk in cutaneous squamous cell carcinoma

19 Jun 2022

Pandemic-caused treatment delays for cancer may aggravate psychological distress

18 Jun 2022

Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.

Pandemic-caused treatment delays for cancer may aggravate psychological distress

18 Jun 2022

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

16 Jun 2022

Use of dostarlimab, a single-agent programmed death 1 (PD-1) monoclonal antibody, appears to have successfully cured mismatch repair-deficient, locally advanced rectal cancer, reports a recent study.

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

16 Jun 2022

Sweetened drinks, sugar intake up incidence, mortality of proximal colon cancer

15 Jun 2022 bởi

Consumption of sugar and sugar-sweetened beverages (SSBs) appears to increase proximal colon cancer incidence and mortality, particularly during later stage of tumorigenesis, reports a study.

Sweetened drinks, sugar intake up incidence, mortality of proximal colon cancer

15 Jun 2022

$Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC$

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

15 Jun 2022

The fixed-dose combination of trifluridine/tipiracil may be feasible for use in the treatment of patients with refractory esophageal squamous cell carcinoma (ESCC), with the drug showing modest clinical activity in the phase II ECTAS study.

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

15 Jun 2022

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

Drug combinations including venetoclax seem to have a positive impact on health-related quality of life (HRQoL), or at least does not worsen it, in patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy, a recent study has found.

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

Cancer patients report high acceptance of telemedicine

14 Jun 2022 bởi

Patients with cancer are not averse to telemedicine, reporting satisfaction with their experience, according to a Singapore study. This high acceptance is associated with facilitating conditions such as having necessary resources and perceived improved access.

Cancer patients report high acceptance of telemedicine

14 Jun 2022

Clear guidelines needed for closed-system transfer device use with cancer drugs

13 Jun 2022 bởi

A survey of Canadian healthcare practitioners reveals a lack of clarity on closed-system transfer device (CSTD) compatibility with oncology biologics, as well as the lack of control drug manufacturers have as a single stakeholder to protect the quality of their products and the safety of patients who use them.

Clear guidelines needed for closed-system transfer device use with cancer drugs

13 Jun 2022

Postresection chemoradiotherapy does not prevent second primary tumours in ESCC

13 Jun 2022

In patients with early esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) following endoscopic resection (ER) does not seem to reduce the incidence of developing second primary ESCC nor cancers in other organs when compared with ER alone, according to a study.

Postresection chemoradiotherapy does not prevent second primary tumours in ESCC

13 Jun 2022

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Active tea catechin eases radiation burns

Active tea catechin eases radiation burns

Adjuvant radiation halves recurrence risk in cutaneous squamous cell carcinoma

Adjuvant radiation halves recurrence risk in cutaneous squamous cell carcinoma

Pandemic-caused treatment delays for cancer may aggravate psychological distress

Pandemic-caused treatment delays for cancer may aggravate psychological distress

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

Sweetened drinks, sugar intake up incidence, mortality of proximal colon cancer

Sweetened drinks, sugar intake up incidence, mortality of proximal colon cancer

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

Trifluridine/tipiracil polypill shows modest clinical activity against refractory ESCC

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

Cancer patients report high acceptance of telemedicine

Cancer patients report high acceptance of telemedicine

Clear guidelines needed for closed-system transfer device use with cancer drugs

Clear guidelines needed for closed-system transfer device use with cancer drugs

Postresection chemoradiotherapy does not prevent second primary tumours in ESCC

Postresection chemoradiotherapy does not prevent second primary tumours in ESCC